How 23andMe Went From $6B Valuation to Penny Stock | WSJ What Went Wrong
DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests to homes with just a tube of spit. But challenges with its business model and continued data privacy concerns for consumers have brought the company once valued at $6 billion to a valuation of nearly $0, with Nasdaq threatening to delist it. WSJ explains what went wrong with Wojcicki’s biotech business. Chapters: 0:00 Home DNA testing 0:49 The rise of 23andMe 2:18 The turning point 4:03 23andMe’s fall 5:23 What’s next? What Went Wrong explores the challenging conditions and decisions that led to a company's downturn. #23andMe #DNA #WSJ
▶︎
What Happened To 23andMe?
▶︎
EXPOSED: Ukraine obliterates critical bridge to trap Putin’s forces | Battle Plans
▶︎
They Knew 432 Park Avenue Would Crack Before They Built It
▶︎
The Hidden Backdoors Inside Millions of Smart Devices | WSJ
▶︎
Frankreich – Senegal Highlights | Gruppe I, FIFA WM 2026 | sportstudio
▶︎
If Prime Numbers Become Increasingly Rare, Then Why Do They Keep Showing Up In Pairs?
▶︎
How a Trading Academy Ruined Thousands of Young People’s Lives | Bloomberg Investigates
▶︎
Inside Trump Mobile
▶︎
SpaceX: The IPO where the math doesn't matter | About That
▶︎
S13 E15: Iran, FIFA & UK Elections: 6/14/26: Last Week Tonight with John Oliver
▶︎
Why Saudi Arabia’s $5B LIV Golf Experiment Failed | WSJ What Went Wrong
▶︎
The $2.5 Trillion Tidal Wave Nobody Sees Coming
▶︎
Man with suspended licence joins court call while driving
▶︎
Trump split his base & LOST THE WAR: Attack, retreat, pay for deal
▶︎
Inside Anthropic, the $965 Billion AI Juggernaut | The Circuit
▶︎
The rise and fall of 23andMe
▶︎
How WeWork Went From $47B Startup to Bankrupt Penny Stock | WSJ What Went Wrong
▶︎
11 Of The Most Faked Foods In The World | Big Business | Business Insider Marathon
▶︎
NYC's Joyous Knicks Victory Celebration vs. Trump's Joyless White House UFC Fight | The Daily Show
▶︎